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Abstract

Background: While ventriculo-extracranial shunting procedures
have been the standard treatment option for hydrocephalus for a
long time, their long-term morbidity, including the development
of post-shunt de novo seizures, should be taken into account.
This study aimed to investigate the rate and risk factors of
the occurrence of de novo post-shunt seizures in patients with
hydrocephalus.
Methods: In this retrospective longitudinal study, all patients with
hydrocephalus who had ventriculo-peritoneal shunt insertion from
2014 to 2017 at Namazi Hospital, (Shiraz, Iran) were studied.
Phone calls were made to all patients to obtain their postoperative
seizure outcome and other data (e.g., sex, age at surgery, shunt
insertion location, history of seizures before surgery, history of
seizures after surgery, any other type of brain surgery, and the
etiology of their hydrocephalus). The Pearson Chi Square was
used for the analysis of binary variable (e.g., sex) differences, and
the t test for the analysis of differences in the means of numerical
variables (e.g., age). Bonferroni correction tests were also utilized.
P values less than 0.05 were considered significant.
Results: A total of 114 patients were included in the study.
Overall, 68 (60%) patients had a frontal location of shunt
insertion and 46 (40%) had a parietal site. Twenty-four (21%)
patients reported experiencing de novo post-shunt seizures, 15
of which had a frontal location and nine a parietal location for
shunt insertion (P=0.824).
Conclusion: De novo post-shunt seizures are common
occurrences. However, shunt location is not a significant risk
factor for the development of de novo post-shunt seizures.
Please cite this article as: Bazrafshan H, Masoudi MS, Bazrafshan M,
Asadi-Pooya AA. Is Shunt Location a Risk Factor for the Development of De
Novo Post-shunt Seizures? Iran J Med Sci. 2022;47(2):139-142. doi: 10.30476/
IJMS.2021.88641.1934.
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•
The comorbidity of epilepsy and
hydrocephalus (HC) is mainly due to
the underlying etiology; however, the
treatment (i.e., shunting procedure) has
also been implicated in the development
of epilepsy in some patients.

Introduction

•
De novo post-shunt seizures are
common occurrences. However, shunt
location is not a significant risk factor for
the development of de novo post-shunt
seizures.

Hydrocephalus (HC) is a cerebrospinal fluid (CSF) physiology
disorder that causes abnormal enlargement of the cerebral
ventricles. This disorder has various etiologies.1 Congenital
hydrocephalus, which frequently involves aqueduct stenosis, has
a genetic etiology. Hydrocephalus can also be acquired, mainly
as a result of pathological events affecting ventricular outflow,
subarachnoid space function, or cerebral venous compliance.
Treatment strategies may include shunt and endoscopic
approaches.1 Epilepsy is a major comorbidity in patients with
HC and may have a serious impact on their outcomes.2 The
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comorbidity of epilepsy and HC is mainly
due to the underlying etiology. However, the
treatment (i.e., shunting procedure) has also
been implicated in the development of epilepsy
in some patients.2-5 Despite the reproducibility
of the observation of post-shunt de novo
seizure occurrences in multiple studies,2-6 the
risk factors associated with such sequelae are
contradictory in previous studies. For example,
one study suggested that shunt location is very
important.3 This observation was not reproduced
in any other study.4 While ventriculo-extracranial
shunting procedures have been the standard
treatment option for HC for a long time,1, 2 their
long-term morbidity, including the development
of post-shunt de novo seizures, should be taken
into account.
The current study aimed to investigate the
rate and risk factors of the occurrence of de
novo post-shunt seizures in patients with HC.
In specific, we hypothesized that shunt location
is a significant risk factor for the development
of de novo post-shunt seizures in patients with
HC. The answer to this question could have
significant practical implications.
Patients and Methods
The study was approved by the Review Board
and the Ethics committee of Shiraz University
of Medical Sciences (code: IR.SUMS.
REC.1398.1287). In the current retrospective
longitudinal study, all patients with HC who had
ventriculo-peritoneal shunt insertion between
2014 and 2017 at Namazi Hospital, (Shiraz, Iran)
were studied. There were no exclusion criteria
at this stage. In the initial phase, we reviewed
their medical records to obtain detailed clinical
information such as sex, age at surgery, shunt
insertion location, history of seizures before
surgery, history of seizures after surgery, any
other type of brain surgery, and the etiology of
their HC. The shunt insertion location criteria
were not known in this retrospective study (it was
based on the decision of treating neurosurgeons).

In the second phase, the neurologist, the first
author, made phone calls with all the patients
to verify their medical information, as well as
to obtain their postoperative seizure outcome
(occurrence and frequency of seizures). The
patients were asked if they agreed to share their
information over the phone (no written consent
was obtained). Patients who did not respond to
our phone call, those not willing to participate,
and patients who reported having seizures
before their surgery were excluded. All data has
been kept confidential.
Relevant clinical variables were summarized
descriptively to characterize the study population.
Statistical Analysis
IBM-SPSS statistics (version 25, IBM Corp.USA) was used for statistical analyses. Fisher’s
Exact test was used for the analysis of binary
variable (e.g., sex) differences. The t test was
used for the analysis of differences in the
means of numerical variables (e.g., age), and
Bonferroni correction tests were applied for
statistical analyses. P values less than 0.05
were considered significant.
Results
A total of 114 patients [48 women (42%) and
66 men (58%)] met the inclusion criteria and
entered the study. Their mean age at the time of
the shunt surgery was 46±101 months (range:
0-79 years) and their postoperative follow-up
period was 38±10 months (range: 2-5 years).
Overall, 68 (60%) patients had a frontal location
of shunt insertion, and 46 (40%) had a parietal
site. Twenty-four (21%) patients reported
experiencing de novo post-shunt seizure(s).
There was no difference between frontal versus
parietal shunt locations (P=0.824). Factors that
were potentially associated with the occurrence
of de novo post-shunt seizures are shown in
table 1. Among the 24 patients who reported
experiencing de novo post-shunt seizures, three
had a single seizure, six had well-controlled

Table 1: Factors potentially associated with the occurrence of de novo post-shunt epileptic seizures
Variable
Patients with de novo post- Patients without de novo postshunt seizures (N=24)
shunt seizures (N=90)
Sex
Female
3 (13%)
45 (50%)
Male
21 (87%)
45 (50%)
Age at surgery (Mean±SD) (month)
56±62
43±109
Etiology of hydrocephalus Congenital
10 (42%)
59 (66%)
Acquired
14 (58%)
31 (34%)
Other brain surgery
6 (25%)
15 (17%)
Shunt location
Frontal
15 (63%)
53 (59%)
Parietal
9 (37%)
37 (41%)
*After Bonferroni correction, significant predictive value is 0.01. 1Fisher’s Exact test; 2t test

140

P value
0.0011
0.5852
0.0581
0.3791
0.8181
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seizures (i.e., no seizure in the past 12 months),
and 15 had uncontrolled seizures (i.e., having
seizures in the past 12 months despite receiving
antiepileptic drugs for 13 months or after the
discontinuation of their drugs in two months).
Discussion
In this study, we observed that de novo seizures
occur in 21% of patients with HC, who receive
ventriculo-extracranial shunting procedures. This
rate is similar to that in one previous report,5 while
it is higher in another study.3 The development
of de novo post-shunt seizures could be directly
related to shunt implantation.5 De novo seizures
may also happen following other types of brain
surgery.7-10 This observation has significant
clinical and practical implications. First, it is
reasonable to consider using alternative CSF
diversionary techniques, when they are clinically
appropriate,3 or using alternative procedures,
such as endoscopic third ventriculostomy (ETV),
to treat HC, when anatomically possible.5 In
newborns with HC, initial treatment with ETV
is preferable to the implantation of a shunt. In
adults with HC, ETV failed sooner than shunt
therapy; nonetheless, ETV was more efficient.11
In addition, the incidence of complications and
mortality is higher with the shunting procedure.12
Secondly, it is important to identify the risk
factors that predispose patients with HC to the
development of de novo post-shunt seizures.
Many studies have previously tried to provide a
list of these risk factors.2-6 The most consistent
risk factor for the development of de novo
post-shunt seizures in the literature is shunt
complications (e.g., shunt infection).5 We did not
investigate shunt complications in our study.
Shunt location was not a significant risk
factor for the development of de novo post-shunt
seizures in patients with HC in our study. One
previous study suggested that shunt location is
important in the development of de novo postshunt seizures in patients with HC.3 However,
this observation was not reproduced in any other
study.4 A recent study comparing complications
and revision rates following frontal versus parietal
approaches for ventricular shunt placement
in patients with idiopathic normal pressure
HC found that shunt location may not have a
significant impact on complications and revision
rates, and either approach is reasonable.13 This
is consistent with our findings.
We observed that sex was a significant risk
factor for the development of de novo post-shunt
seizures in patients with HC. The development
rate of de novo post-shunt seizures in men
(32%) was five times higher than in women (6%).
Iran J Med Sci March 2022; Vol 47 No 2

In one previous study, the authors observed that
men had greater odds for multiple revisions than
women.14 The relationship between male sex
and shunt complications/sequels is an intriguing
observation and should be explored in future
studies.
Age at the time of the shunting procedure
was not associated with the development of
de novo post-shunt seizures in our study. This
is consistent with the findings of a previous
study.3 Etiology of HC was not associated
with the development of de novo post-shunt
seizures in our study either. Similarly, one
study has suggested that there is no significant
association between shunt malfunction and the
etiology of the HC or patient’s age.15 However,
the association between the original cause of
HC and the development rate of epilepsy is a
controversial issue in the literature.5 This issue
should be resolved in future studies.
Our study has a limitation; the retrospective
design of our study restricted our ability to
differentiate between de novo post-shunt
provoked versus unprovoked seizures. In
addition, we did not investigate some of the
potentially important risk factors, including shunt
complications.
Conclusion
In conclusion, de novo post-shunt seizures
are common occurrences and require serious
attention. When possible, it is reasonable to
consider using alternative techniques instead
of ventriculo-extracranial shunting procedures.
If performing ventriculo-extracranial shunting
procedures is mandatory, it is important to try
to prevent and minimize the risk factors for the
development of de novo post-shunt seizures. It
seems that shunt location is not a significant risk
factor for the development of de novo post-shunt
seizures in patients with HC.
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